Actively Recruiting

Age: 18Years - 70Years
All Genders
Healthy Volunteers
NCT06068114

Gastric Pathophysiology in Diabetes

Led by Institute for Clinical and Experimental Medicine · Updated on 2024-05-17

120

Participants Needed

5

Research Sites

247 weeks

Total Duration

On this page

Sponsors

I

Institute for Clinical and Experimental Medicine

Lead Sponsor

P

Poliklinika Agel, Dopravni zdravotnictvi a.s.

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a comprehensive pathophysiological study assessing various gastric functions in patients with diabetes mellitus. The investigators aim to examine the stomach with various measurement devices to gain information about its different functions and malfunctions. After the initial measurements, the examinations will be repeated after a year in each patient. Changes in the measurement values will be examined and their relations to each other and to the overall health of the patients will be investigated. For example it is hypothesised that diabetic patients also suffering from functional dyspepsia or gastroparesis will also show some changes in the function of the pyloric muscle.

CONDITIONS

Official Title

Gastric Pathophysiology in Diabetes

Who Can Participate

Age: 18Years - 70Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diabetes mellitus type I or II with a minimum disease duration of 3 years
  • Specific diabetes treatment (drugs or insulin) for at least 2 years
Not Eligible

You will not qualify if you...

  • Type II diabetes treated only with diet
  • Severe acute uncontrolled diabetes requiring hospitalization
  • Treatment with more than one prokinetic agent
  • Current or past 12 months treatment with opioids
  • Previous major esophageal or gastric surgery
  • Organic pyloric or intestinal obstruction
  • Severe coagulopathy
  • Esophageal or gastric varices or portal gastropathy
  • Advanced liver cirrhosis
  • Pregnancy or puerperium
  • Malignant or pre-malignant gastric diseases, except cured cases
  • Rumination syndrome or eating disorders such as anorexia nervosa or bulimia
  • Systemic connective tissue disorder
  • Inability to give informed consent
  • Any condition interfering with study requirements according to the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Nemocnice AGEL Ostrava-Vítkovice a. s.

Ostrava, Czechia, 703 00

Actively Recruiting

2

University Hospital Ostrava

Ostrava, Czechia, 708 52

Actively Recruiting

3

Institute for Clinical and Experimental Medicine

Prague, Czechia, 14021

Actively Recruiting

4

Military University Hospital Prague

Prague, Czechia, 16902

Actively Recruiting

5

University Hospital Trnava

Trnava, Slovakia, 917 02

Actively Recruiting

Loading map...

Research Team

E

Eva Evinová, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here